Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1

Despite advances in cancer detection and prevention, a diagnosis of metastatic disease remains a death sentence due to the fact that many cancers are either resistant to chemotherapy (conventional or targeted) or develop resistance during treatment, and residual chemoresistant cells are highly metas...

Descripción completa

Detalles Bibliográficos
Autores principales: Sims, Jonathan T., Ganguly, Sourik S., Bennett, Holly, Friend, J. Woodrow, Tepe, Jessica, Plattner, Rina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561297/
https://www.ncbi.nlm.nih.gov/pubmed/23383209
http://dx.doi.org/10.1371/journal.pone.0055509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561297/
https://www.ncbi.nlm.nih.gov/pubmed/23383209
http://dx.doi.org/10.1371/journal.pone.0055509

Ejemplares similares